Spring direct naar de hoofdnavigatie of de inhoud

New on Kluwer Patent Blog: Accord Healthcare Ltd. vs. Shire-NPS Pharmaceuticals Inc., Netherlands

New on Kluwer Patent Blog: Accord Healthcare Ltd. vs. Shire-NPS Pharmaceuticals Inc., Netherlands

New on Kluwer Patent Blog: Accord Healthcare Ltd. vs. Shire-NPS Pharmaceuticals Inc., Netherlands

The Court held that a selection invention is inventive if the compound of the selection offers surprisingly advantageous or improved properties over the prior art compounds. These properties should already be plausible from the patent application as filed. Further, a selection invention would be obvious to the skilled person if they would assume a neutral ‘try and see’ approach on the basis of the prior art information, and no explicit chance of success needs to be present.

Read the full article by Bart van Wezenbeek on Kluwer IP Law.

Also see these experts

Marco Molling

Marco Molling

  • European Patent Attorney
  • Dutch Patent Attorney
  • Belgian Patent Attorney
  • Partner
Peter de Lange

Peter de Lange

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts